**Author details**

M. Magdalena Aguirre-García1 \*, Araceli Rojas-Bernabé2,3, A. Pamela Gómez-García1 and Alma R. Escalona-Montaño1

1 División de Investigación, Facultad de Medicina, Instituto Nacional de Cardiología Ignacio Chávez, Unidad de Investigación UNAM-INC, Ciudad de México, Mexico

2 Escuela Superior de Medicina, Instituto Politécnico Nacional, Salvador Díaz Mirón, Col. Casco Santo Tomas, Ciudad de México, Mexico

3 Hospital de la Mujer, SSA, Col. Santo Tomas, Ciudad de México, Mexico

\*Address all correspondence to: maguirre@unam.mx

© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**51**

*TLR-Mediated Host Immune Response to Parasitic Infectious Diseases*

One. 2014;**9**(11):e112410. Available from: http://www.ncbi.nlm.nih.gov/

[6] Oliaee RT, Sharifi I, Afgar A, Jafarzadeh A, Kareshk AT, Bamorovat M, et al. Differential expression of TLRs 2, 4, 9, iNOS and TNF-alpha and arginase activity in peripheral blood monocytes from glucantime unresponsive and responsive patients with anthroponotic cutaneous leishmaniasis caused by *Leishmania tropica*. Microbial Pathogenesis. 2018;**126**:368-378. Available from: http://www.ncbi.nlm.nih.gov/

pubmed/25397678

pubmed/30399441

pubmed/17072450

pubmed/18448974

pubmed/16774587

[7] Teixeira ARL, Nascimento RJ, Sturm NR. Evolution and pathology in chagas disease—A review. Memórias do Instituto Oswaldo Cruz. 2006;**101**(5):463-491. Available from: http://www.ncbi.nlm.nih.gov/

[8] Dutra WO, Gollob KJ. Current concepts in immunoregulation and pathology of human Chagas disease. Current Opinion in Infectious Diseases. 2008;**21**(3):287-292. Available from: http://www.ncbi.nlm.nih.gov/

[9] Grace E, Asbill S, Virga K. Naegleria fowleri: Pathogenesis, diagnosis, and treatment options. Antimicrobial Agents and Chemotherapy. 2015;**59**(11): 6677-6681. Available from: http://www. ncbi.nlm.nih.gov/pubmed/26259797

[10] Khan NA. Acanthamoeba: Biology and increasing importance in human health. FEMS Microbiology Reviews. 2006;**30**(4):564-595. Available from: http://www.ncbi.nlm.nih.gov/

[11] Martinez AJ, Visvesvara GS. Free-living, amphizoic and

opportunistic amebas. Brain Pathology.

*DOI: http://dx.doi.org/10.5772/intechopen.84679*

[1] Achtman JC, Ellis DL, Saylors B, Boh EE. Cutaneous leishmaniasis caused by Leishmania (Viannia) panamensis in 2 travelers. JAAD Case Reports. 2016;**2**(2):95-97. Available from: http://www.ncbi.nlm.nih.gov/

[2] Sacramento L, Trevelin SC,

Nascimento MS, Lima-Junior DS, Costa DL, Almeida RP, et al. Toll-like receptor 9 signaling in dendritic cells regulates neutrophil recruitment to inflammatory foci following *Leishmania infantum* infection. Infection and Immunity. 2015;**83**(12):4604-4616. Available from: http://www.ncbi.nlm.nih.gov/

[3] Cezario GA, de Oliveira LR, Peresi E, Nicolete VC, Polettini J, de Lima CR, et al. Analysis of the expression of toll-like receptors 2 and 4 and cytokine production during experimental *Leishmania chagasi* infection. Memórias do Instituto Oswaldo Cruz. 2011;**106**(5):573-583. Available from: http://www.ncbi.nlm.nih.gov/

[4] Campos MB, Lima L, de Lima ACS, Vasconcelos Dos Santos T, Ramos PKS, Gomes CMC, et al. Toll-like receptors 2, 4, and 9 expressions over the entire clinical and immunopathological spectrum of American cutaneous leishmaniasis due to *Leishmania* (V.) *braziliensis* and *Leishmania* (L.) *amazonensis*. PLoS One. 2018;**13**(3):e0194383. Available from: http://www.ncbi.nlm.nih.gov/

[5] Caneda-Guzman IC, Salaiza-Suazo N, Fernandez-Figueroa EA, Carrada-Figueroa G, Aguirre-Garcia M, Becker I. NK cell activity differs between patients with localized and diffuse cutaneous leishmaniasis infected with *Leishmania mexicana*: A comparative study of TLRs and cytokines. PLoS

**References**

pubmed/27051841

pubmed/26371124

pubmed/21894379

pubmed/29543867

*TLR-Mediated Host Immune Response to Parasitic Infectious Diseases DOI: http://dx.doi.org/10.5772/intechopen.84679*
